Diagnostic strategy to improve the efficiency of screening diabetes—ROC analysis for fasting plasma glucose

资源类型:pdf 资源大小:100.00KB 文档分类: 上传者:曾祥炎




【作者】 Junxi Lu  Weiping Jia  Lei Chen  Yuanmin Wu  Yuhua Zuo  Kunsan Xiang 

【关键词】Esophageal cancer  Polymorphism  EPHX1 


【摘要】Genetic polymorphisms in xenobiotic metabolizing enzymes may alter risk of various cancers. Present case-control study evaluated the influence of <i>EPHX1</i> genetic variations on squamous cell esophageal cancer (ESCC) susceptibility in 107 patients and 320 controls. <i>EPHX1</i> polymorphic alleles were genotyped by direct sequencing (exon 3, <i>Tyr113His</i>) or PCR-RFLP (exon 4, <i>His139Arg</i>). Patients with exon 3 genotypes (<i>Tyr113His, His113His</i>) and 113His allele were at risk of ESCC (OR<sub><i>Tyr113His</i></sub> 2.0, 95%CI = 1.2&#x2013;3.4, <i>p</i> = 0.007; OR<sub><i>His113His</i></sub> 2.3 95%CI = 1.0&#x2013;5.2, <i>p</i> = 0.03 and OR<sub><i>His</i></sub> 1.5, 95%CI = 1.0&#x2013;2.1, <i>p</i> = 0.01). In contrast, individuals with exon 4, <i>139Arg</i> allele were at low risk of cancer (OR 0.34, 95%CI = 0.20&#x2013;0.56, <i>p</i> = 0.001). However, none of haplotype combinations of exon 3 (<i>Tyr113His</i>) and exon 4 (<i>His139Arg</i>) polymorphisms showed modulation of risk for ESCC. Sub-grouping of patients based on anatomical location of tumor predicted that patients with exon 3, <i>His113His</i> and <i>Tyr113His</i> genotypes were at higher risk for developing ESCC tumor at upper and middle third locations (OR 4.4, 95%CI = 1.0&#x2013;18.5, <i>p</i> = 0.04; OR 2.5, 95%CI = 1.3&#x2013;5.0, <i>p</i> = 0.005 respectively). The frequency of exon 4, <i>His139Arg</i> genotype was significantly lower in ESCC patients with lower third tumor location as compared to controls (14.8%vs. 36.3%, <i>p</i> = 0.02). In case-only study, gene-environment interaction of <i>EPHX1</i> genotypes with tobacco, alcohol and occupational exposures did not appear to modulate the cancer susceptibility. In conclusion, exon 3, <i>Tyr113His</i> genotype was associated with higher risk of ESCC particularly at upper and middle-third anatomical locations of tumor. However, <i>His139Arg</i> genotype of exon 4, exhibited low risk for ESCC as well as its clinical characteristics.

【刊名】Diabetes Research and Clinical Practice